F. Hoffmann-La Roche Ltd:企業の戦略・SWOT・財務情報

◆英語タイトル:F. Hoffmann-La Roche Ltd - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C13656
◆発行会社(調査会社):MarketLine
◆発行日:2019年2月
◆ページ数:74
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥18,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥37,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥56,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

F. Hoffmann-La Roche Ltd – Strategy, SWOT and Corporate Finance Report
Summary

F. Hoffmann-La Roche Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

F. Hoffmann-La Roche Ltd (Roche or ‘the company’) is one of the leading research-focused healthcare groups in the world. It is involved in the discovery, development and commercialization of innovative therapeutic and diagnostic products. Roche manufactures pharmaceutical products in five main therapeutic areas, namely, oncology, immunology, ophthalmology, infectious diseases, and neuroscience. It manufactures diagnostic products to test blood and other body fluids and tissues. The company has its operations in Europe, North America, Latin America, Asia, Africa, Australia and Oceania. Roche is headquartered in Basel, Switzerland.

Scope

- Detailed information on F. Hoffmann-La Roche Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting F. Hoffmann-La Roche Ltd in the form of a SWOT analysis
- An in-depth view of the business model of F. Hoffmann-La Roche Ltd including a breakdown and examination of key business segments
- Intelligence on F. Hoffmann-La Roche Ltd’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about F. Hoffmann-La Roche Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of F. Hoffmann-La Roche Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess F. Hoffmann-La Roche Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on F. Hoffmann-La Roche Ltd’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
F. Hoffmann-La Roche Ltd: Company Overview
F. Hoffmann-La Roche Ltd: Overview and Key Facts
F. Hoffmann-La Roche Ltd: Overview
F. Hoffmann-La Roche Ltd: Key Facts
F. Hoffmann-La Roche Ltd: Key Employees
F. Hoffmann-La Roche Ltd: Key Employee Biographies
F. Hoffmann-La Roche Ltd: Major Products and Services
F. Hoffmann-La Roche Ltd: Company History
F. Hoffmann-La Roche Ltd: Management Statement
F. Hoffmann-La Roche Ltd: Locations and Subsidiaries
F. Hoffmann-La Roche Ltd: Key Competitors
F. Hoffmann-La Roche Ltd: Company Analysis
F. Hoffmann-La Roche Ltd: Business Description
F. Hoffmann-La Roche Ltd: SWOT Analysis
F. Hoffmann-La Roche Ltd: SWOT Overview
F. Hoffmann-La Roche Ltd: Strengths
F. Hoffmann-La Roche Ltd: Weaknesses
F. Hoffmann-La Roche Ltd: Opportunities
F. Hoffmann-La Roche Ltd: Threats
F. Hoffmann-La Roche Ltd: Corporate Financial Deals Activity
F. Hoffmann-La Roche Ltd: Financial Deals Overview
F. Hoffmann-La Roche Ltd: Targets and Partners
F. Hoffmann-La Roche Ltd: Top Deals 2015 – 2019YTD*
F. Hoffmann-La Roche Ltd: Advisors
F. Hoffmann-La Roche Ltd: Top Legal Advisors
F. Hoffmann-La Roche Ltd: Top Financial Advisors
F. Hoffmann-La Roche Ltd: Mergers and Acquisitions
F. Hoffmann-La Roche Ltd: Corporate Venturing
F. Hoffmann-La Roche Ltd: Partnership
F. Hoffmann-La Roche Ltd: Divestments
F. Hoffmann-La Roche Ltd: Recent Developments
F. Hoffmann-La Roche Ltd: News and Events Summary
F. Hoffmann-La Roche Ltd: Business Expansion
F. Hoffmann-La Roche Ltd: Contracts
F. Hoffmann-La Roche Ltd: Financial Performance
F. Hoffmann-La Roche Ltd: Market Developments
F. Hoffmann-La Roche Ltd: Research & Development
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: F. Hoffmann-La Roche Ltd: Key Facts
Table 2: F. Hoffmann-La Roche Ltd: Key Employees
Table 3: F. Hoffmann-La Roche Ltd: Company History
Table 4: F. Hoffmann-La Roche Ltd: Locations and Subsidiaries
Table 5: F. Hoffmann-La Roche Ltd: Key Competitors
Table 6: F. Hoffmann-La Roche Ltd: Deal Activity by Deal Type - Volume (TTM*)
Table 7: F. Hoffmann-La Roche Ltd: M&A Activity by Geography (TTM*)
Table 8: F. Hoffmann-La Roche Ltd: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 9: F. Hoffmann-La Roche Ltd: M&A Average Deal Size - Value (US$m)
Table 10: F. Hoffmann-La Roche Ltd: Targets and Partners
Table 11: F. Hoffmann-La Roche Ltd: Top Deals 2015 - 2019YTD*
Table 12: F. Hoffmann-La Roche Ltd: Legal Advisor Ranking by Value (US$m)
Table 13: F. Hoffmann-La Roche Ltd: Financial Advisor Ranking by Value (US$m)
Table 14: F. Hoffmann-La Roche Ltd: M&A Volume and Value Trend (2015 - YTD*2019)
Table 15: F. Hoffmann-La Roche Ltd: M&A Activity by Geography (2015 - YTD*2019)
Table 16: F. Hoffmann-La Roche Ltd: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Table 17: F. Hoffmann-La Roche Ltd: Corporate Venturing by Geography (2015 - YTD*2019)
Table 18: F. Hoffmann-La Roche Ltd: Partnership Volume and Value Trend (2015 - YTD*2019)
Table 19: F. Hoffmann-La Roche Ltd: Partnership Trend by Deal Type (2015 - YTD*2019)
Table 20: F. Hoffmann-La Roche Ltd: Divestments Volume and Value Trend (2015 - YTD*2019)
Table 21: F. Hoffmann-La Roche Ltd: News and Events Summary
Table 22: F. Hoffmann-La Roche Ltd: Business Expansion
Table 23: F. Hoffmann-La Roche Ltd: Contracts
Table 24: F. Hoffmann-La Roche Ltd: Financial Performance
Table 25: F. Hoffmann-La Roche Ltd: Market Developments
Table 26: F. Hoffmann-La Roche Ltd: Research & Development

List of Figures
Figure 1: F. Hoffmann-La Roche Ltd: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: F. Hoffmann-La Roche Ltd: M&A Activity by Geography (TTM*)
Figure 3: F. Hoffmann-La Roche Ltd: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Figure 4: F. Hoffmann-La Roche Ltd: M&A Average Deal Size - Value (US$m)
Figure 5: F. Hoffmann-La Roche Ltd: M&A Volume and Value Trend (2015 - YTD*2019)
Figure 6: F. Hoffmann-La Roche Ltd: M&A Activity by Geography (2015 - YTD*2019)
Figure 7: F. Hoffmann-La Roche Ltd: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Figure 8: F. Hoffmann-La Roche Ltd: Corporate Venturing by Geography (2015 - YTD*2019)
Figure 9: F. Hoffmann-La Roche Ltd: Partnership Volume and Value Trend (2015 - YTD*2019)
Figure 10: F. Hoffmann-La Roche Ltd: Partnership Trend by Deal Type (2015 - YTD*2019)
Figure 11: F. Hoffmann-La Roche Ltd: Divestments Volume and Value Trend (2015 - YTD*2019)

★海外企業調査レポート[F. Hoffmann-La Roche Ltd:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SeraCare Life Sciences, Inc.:医療機器:M&Aディール及び事業提携情報
    Summary SeraCare Life Sciences, Inc. (SeraCare) carries out the discovery, development, manufacture and supply of disease-state specimens and tissues for research and development, processed biological materials, immunoassay reagents and quality control products and technologies. Its major products i …
  • TopiVert Ltd-製薬・医療分野:企業M&A・提携分析
    Summary TopiVert Ltd (TopiVert) is a drug development company that offers disease control solutions in inflammatory diseases of the gastrointestinal tract and the eye. The company develops and offers narrow spectrum kinase inhibitors (NSKI) for the treatment of chronic inflammatory diseases of gastr …
  • CD Diagnostics Inc-医療機器分野:企業M&A・提携分析
    Summary CD Diagnostics Inc (CD Diagnostics), a subsidiary of Zimmer Biomet Holdings Inc is an integrated diagnostics company that develops immunoassays that improve patient outcomes. The company provides synovascure analytical tools. Its products are used in alpha defenses, CRP, hemoglobin tests, in …
  • Shin-Etsu Chemical Co Ltd (4063):企業の財務・戦略的SWOT分析
    Shin-Etsu Chemical Co Ltd (4063) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Hoerbiger Holding AG:企業の戦略的SWOT分析
    Hoerbiger Holding AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Covea Insurance plc:企業の戦略・SWOT・財務情報
    Covea Insurance plc - Strategy, SWOT and Corporate Finance Report Summary Covea Insurance plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Credit Agricole CIB S.A.:企業の戦略的SWOT分析
    Credit Agricole CIB S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Karoon Gas Australia Ltd (KAR):企業の財務・戦略的SWOT分析
    Karoon Gas Australia Ltd (KAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Landesbank Hessen Thueringen Girozentrale:企業の戦略・SWOT・財務情報
    Landesbank Hessen Thueringen Girozentrale - Strategy, SWOT and Corporate Finance Report Summary Landesbank Hessen Thueringen Girozentrale - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Sumitomo Realty & Development Co., Ltd.:企業の戦略・SWOT・財務情報
    Sumitomo Realty & Development Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Realty & Development Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • PharmaCyte Biotech Inc (PMCB)-製薬・医療分野:企業M&A・提携分析
    Summary PharmaCyte Biotech Inc (PharmaCyte), formerly Nuvilex Inc is a clinical stage biotechnology company that develops and commercializes treatments for cancer and diabetes. The company’s technology is used for the treatment of advanced and inoperable pancreatic cancer, and diabetes. It develops …
  • Petrichor Energy Inc (PTP):石油・ガス:M&Aディール及び事業提携情報
    Summary Petrichor Energy Inc (Petrichor Energy), formerly Odyssey Petroleum Corp is an oil and gas company that acquires, explores and develops oil and natural gas reserves in the Americas. The company provides projects such as Verba Field, Marble Falls Prospect, and others. It offes its services fo …
  • Greggs Plc:企業の戦略・SWOT・財務情報
    Greggs Plc - Strategy, SWOT and Corporate Finance Report Summary Greggs Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • China Resources Gas Group Ltd (1193):企業の財務・戦略的SWOT分析
    China Resources Gas Group Ltd (1193) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Aflac Incorporated:企業の戦略・SWOT・財務情報
    Aflac Incorporated - Strategy, SWOT and Corporate Finance Report Summary Aflac Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Terme Dobrna d.d.:企業の戦略・SWOT・財務情報
    Terme Dobrna d.d. - Strategy, SWOT and Corporate Finance Report Summary Terme Dobrna d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • AnGes Inc (4563):医療機器:M&Aディール及び事業提携情報
    Summary AnGes Inc (AnGes) is a biopharmaceutical company which discovers and develops gene and nucleotide based drugs and reagents for use in functional analysis of genetic medication. The company specializes in research and development (R&D) and practical application of genetic medicine. It has two …
  • ARUP Laboratories:企業の戦略的SWOT分析
    ARUP Laboratories - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Mitralign Inc:医療機器:M&Aディール及び事業提携情報
    Summary Mitralign Inc (Mitralign) is a medical device company that offers direct transcatheter annuloplasty system to treat both functional tricuspid regurgitation and mitral regurgitation. The company’s products include crossing wire, pledget delivery catheter and placation lock delivery catheter, …
  • Sumitomo Heavy Industries Construction Cranes Co., Ltd.
    Sumitomo Heavy Industries Construction Cranes Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Heavy Industries Construction Cranes Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the compan …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆